Zenas BioPharma Alternatives & Competitors
12 companies similar to Zenas BioPharma — Enabling patients with autoimmune diseases to reimagine life
Companies similar to Zenas BioPharma
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
Biocon
Transforming Healthcare. Transforming Lives.
Bengaluru, India
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Rival Readout
Competing with Zenas BioPharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Immunocore
Science to Transform Lives
Abingdon, United Kingdom
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
Menlo Park, United States
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
About Zenas BioPharma
Zenas BioPharma, founded in 2020, is a clinical-stage global biopharmaceutical company headquartered in the United States. The company is devoted to transforming the lives of patients with autoimmune diseases, as encapsulated by its slogan: "Enabling patients with autoimmune diseases to reimagine life". Zenas focuses o...
Development of therapies for autoimmune diseases, Clinical trial management, Drug research and development, Commercialization of new therapies
Patients with autoimmune diseases, Healthcare providers, Caregivers, Pharmaceutical investors
Biopharmaceuticals, Autoimmune Diseases, Clinical-stage, Transformative Therapies, Monoclonal Antibody, BTK Inhibitor, CNS-penetrant, Small Molecule, Subcutaneous Injection, B Cell Lineage, Immunology, Macrophage Modulation, Microglial Cells, IL-17 Inhibitor, TYK2 Inhibitor
B2B
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Zenas BioPharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Zenas BioPharma on 9 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
